|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
CN105939767B
(zh)
|
2014-01-08 |
2018-04-06 |
弗洛设计声能学公司 |
具有双声电泳腔的声电泳装置
|
|
WO2015109391A1
(en)
|
2014-01-24 |
2015-07-30 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Smc combination therapy for the treatment of cancer
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
KR20230133934A
(ko)
|
2016-10-11 |
2023-09-19 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
KR20240024328A
(ko)
|
2016-11-22 |
2024-02-23 |
알로플렉스 바이오테라퓨틱스 |
동종이형 종양 세포 백신
|
|
US11185586B2
(en)
|
2016-11-22 |
2021-11-30 |
Alloplex Biotherapeutics, Inc. |
Allogeneic tumor cell vaccine
|
|
AU2018223211B2
(en)
*
|
2017-02-21 |
2025-02-27 |
Adelaide university |
T cells expressing chemokine receptors for treating cancer
|
|
KR20190141695A
(ko)
|
2017-04-13 |
2019-12-24 |
센티 바이오사이언시스, 인코포레이티드 |
병용 암 면역요법
|
|
JP2020517263A
(ja)
*
|
2017-04-19 |
2020-06-18 |
ユニバーシティ オブ サザン カリフォルニア |
がんを治療するための組成物及び方法
|
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
WO2019025800A1
(en)
*
|
2017-08-02 |
2019-02-07 |
Autolus Limited |
CELLS EXPRESSING A CHIMERIC ANTIGENIC RECEPTOR OR A MANIPULATED TCR AND COMPRISING A SELECTIVELY EXPRESSED SELECTIVE NUCLEOTIDE SEQUENCE
|
|
GB201713078D0
(en)
*
|
2017-08-15 |
2017-09-27 |
Adaptimmune Ltd |
T Cell Modification
|
|
JP2020532987A
(ja)
*
|
2017-09-08 |
2020-11-19 |
ポセイダ セラピューティクス，インコーポレイティド |
キメラリガンド受容体（ｃｌｒ）介在性の条件遺伝子発現のための組成物および方法
|
|
WO2019077037A1
(en)
*
|
2017-10-18 |
2019-04-25 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
METHODS AND COMPOUNDS FOR ENHANCED IMMUNE CELL THERAPY
|
|
CN114900773A
(zh)
|
2017-12-14 |
2022-08-12 |
弗洛设计声能学公司 |
声泳系统及其操作方法、控制声换能器及声学系统的方法
|
|
GB201721802D0
(en)
*
|
2017-12-22 |
2018-02-07 |
Almac Discovery Ltd |
Ror1-specific antigen binding molecules
|
|
EP3619313B9
(en)
*
|
2018-02-15 |
2023-10-04 |
The National Institute for Biotechnology in the Negev Ltd. |
Tumor environment-specific expression of chimeric antigen receptors
|
|
US20210113594A1
(en)
*
|
2018-03-13 |
2021-04-22 |
Osaka University |
Tumor immunomodulator
|
|
EP3781176A4
(en)
*
|
2018-04-09 |
2022-05-25 |
The Trustees of the University of Pennsylvania |
METHODS AND COMPOSITIONS USING A VIRAL VECTOR FOR THE EXPRESSION OF A TRANSGENE AND AN EFFECTOR
|
|
CN110615842B
(zh)
*
|
2018-06-20 |
2023-05-09 |
上海隆耀生物科技有限公司 |
一种包含共刺激受体的嵌合抗原受体及应用
|
|
CN108913718A
(zh)
*
|
2018-07-20 |
2018-11-30 |
苏州茂行生物科技有限公司 |
一种靶向EGFR vⅢ的CAR-T细胞的制备方法及应用
|
|
CN108949825A
(zh)
*
|
2018-07-30 |
2018-12-07 |
苏州茂行生物科技有限公司 |
一种靶向her2的car-t细胞的制备方法及应用
|
|
US11866494B2
(en)
*
|
2018-08-31 |
2024-01-09 |
Innovative Cellular Therapeutics Holdings, Ltd. |
CAR T therapy through uses of co-stimulation
|
|
US20210317184A1
(en)
*
|
2018-09-05 |
2021-10-14 |
GlaxoSmithKline Intellectual Property Devolopment Limited |
T cell modification
|
|
WO2020052543A1
(en)
|
2018-09-10 |
2020-03-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against cd33 and constructs thereof
|
|
CA3116138A1
(en)
|
2018-10-17 |
2020-04-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
US12257286B2
(en)
|
2018-10-31 |
2025-03-25 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US12264189B2
(en)
|
2018-10-31 |
2025-04-01 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US12624086B2
(en)
|
2018-10-31 |
2026-05-12 |
Mayo Foundation For Medical Education And Research |
Materials and methods for treating cancer
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
SG11202105975SA
(en)
*
|
2018-12-06 |
2021-07-29 |
Guangdong Tcrcure Biopharma Technology Co Ltd |
Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpoints
|
|
CA3129263A1
(en)
*
|
2019-02-08 |
2020-08-13 |
Dna Twopointo Inc. |
Transposon-based modifications of immune cells
|
|
US12419913B2
(en)
|
2019-02-08 |
2025-09-23 |
Dna Twopointo, Inc. |
Modification of CAR-T cells
|
|
EP3927371A1
(en)
*
|
2019-02-22 |
2021-12-29 |
Novartis AG |
Combination therapies of egfrviii chimeric antigen receptors and pd-1 inhibitors
|
|
US20220175833A1
(en)
*
|
2019-03-07 |
2022-06-09 |
Children's Medical Center Corporation |
Targeted delivery of immune-modulating vhh and vhh-fusion protein
|
|
US20220204575A1
(en)
*
|
2019-04-23 |
2022-06-30 |
The Regents Of The University Of California |
Modulating survival of therapeutic cells and methods, cells and nucleic acids related thereto
|
|
US11026973B2
(en)
|
2019-04-30 |
2021-06-08 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
US20220291203A1
(en)
*
|
2019-07-25 |
2022-09-15 |
Immunowake Inc. |
Methods of measuring cell-mediated killing by effectors
|
|
CA3149395A1
(en)
*
|
2019-08-01 |
2021-02-04 |
Memorial Sloan-Kettering Cancer Center |
Cells for improved immunotherapy and uses thereof
|
|
WO2021041920A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
WO2021046243A2
(en)
|
2019-09-03 |
2021-03-11 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
MX2022004772A
(es)
*
|
2019-10-22 |
2022-07-19 |
Alloplex Biotherapeutics |
Composiciones y métodos para la activación y la expansión in vitro de poblaciones de linfocitos t citolíticos en serie e inmunización pasiva de un paciente de cáncer con células tumorales asesinas.
|
|
CN115297873A
(zh)
*
|
2019-11-08 |
2022-11-04 |
梅约医学教育与研究基金会 |
利用工程化改造的间充质干细胞治疗炎症和退行性疾病的方法和物质
|
|
CN112941028A
(zh)
*
|
2019-12-09 |
2021-06-11 |
上海细胞治疗集团有限公司 |
纳米抗体基因修饰的间充质干细胞及其制备方法与应用
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
AU2021208433A1
(en)
*
|
2020-01-14 |
2022-07-14 |
Uswm Ct, Llc |
Method of treatment of cancer or tumour
|
|
WO2021173844A1
(en)
*
|
2020-02-26 |
2021-09-02 |
Biograph 55, Inc. |
C19 c38 bispecific antibodies
|
|
WO2021197430A1
(en)
*
|
2020-04-01 |
2021-10-07 |
Nanjing Legend Biotech Co., Ltd. |
Compositions and methods for reducing graft rejection in allogeneic cell therapy
|
|
CN116096433A
(zh)
*
|
2020-06-29 |
2023-05-09 |
纪念斯隆凯特琳癌症中心 |
表达c825的免疫细胞及其诊断用途
|
|
JP7846667B2
(ja)
|
2020-07-16 |
2026-04-15 |
レジェンド バイオテック アイルランド リミテッド |
Ｃｄ２０結合分子及びその使用
|
|
CA3186065A1
(en)
|
2020-07-16 |
2022-01-20 |
Xiaohu FAN |
Cd19 binding molecules and uses thereof
|
|
AU2021334950A1
(en)
*
|
2020-08-24 |
2023-03-02 |
Charité - Universitätsmedizin Berlin |
Chimeric antigen receptor (CAR)-expressing cells recognizing CEA
|
|
TW202233830A
(zh)
*
|
2020-10-27 |
2022-09-01 |
美商Ｐａｃｔ製藥公司 |
使用下一代工程化t細胞療法治療癌症之組合物及方法
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US12234473B2
(en)
|
2020-12-31 |
2025-02-25 |
Immatics US, Inc. |
CD8 polypeptides, compositions, and methods of using thereof
|
|
KR20240013094A
(ko)
|
2021-03-17 |
2024-01-30 |
마이얼로이드 테라퓨틱스, 인크. |
조작된 키메라 융합 단백질 조성물 및 그의 사용 방법
|
|
WO2022241029A1
(en)
|
2021-05-11 |
2022-11-17 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
CN117769594A
(zh)
*
|
2021-06-24 |
2024-03-26 |
乔治亚技术研究公司 |
用于通过热靶向远程控制t细胞疗法的方法和组合物
|
|
CN113789299B
(zh)
*
|
2021-10-18 |
2023-03-24 |
新鲁细胞生物科技(海南)有限公司 |
一种脐血nk细胞的体外增殖培养基、体外培养试剂盒和体外培养方法
|
|
TW202426477A
(zh)
*
|
2022-10-07 |
2024-07-01 |
美商聖堤生物科技股份有限公司 |
經武裝之嵌合受體及其使用方法
|
|
WO2024107410A1
(en)
*
|
2022-11-14 |
2024-05-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cd39 selection for cytotoxicity of genetically engineered t regulatory cells
|
|
TW202440636A
(zh)
|
2023-03-21 |
2024-10-16 |
美商傳記５５有限公司 |
Ｃｄ１９／ｃｄ３８多特異性抗體
|
|
FI131854B1
(en)
|
2023-05-29 |
2026-01-12 |
Onni Biotechnologies Oy |
Modified natural killer cells with enhanced cytotoxic activity and greater survival
|
|
WO2025081190A1
(en)
*
|
2023-10-12 |
2025-04-17 |
Georgia Tech Research Corporation |
Image guided car t cell therapy to treat brain tumors
|